Clinical Trials Logo

Warts clinical trials

View clinical trials related to Warts.

Filter by:

NCT ID: NCT05254561 Completed - Clinical trials for Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts

Triple Antigen vs Monoantigen Immunotherapy for Warts

Start date: November 20, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

Warts can be resistant to treatment or return despite the use of many therapeutic modalities. Combining immunotherapy might contribute to better response rates, particularly in recalcitrant warts, which is a real therapeutic challenge. The purpose of this study was to assess the effectiveness and safety of a triple intralesional immunotherapy combination composed of PPD, Candida antigen and MMR versus either agent alone in the management of multiple recalcitrant warts.

NCT ID: NCT05198180 Not yet recruiting - Plantar Wart Clinical Trials

Treatment of Plantar Warts

Start date: February 2022
Phase: Phase 3
Study type: Interventional

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.

NCT ID: NCT05156541 Completed - Clinical trials for Human Papillomavirus Infection

Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts

ING-HPV-1
Start date: May 18, 2009
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the effectiveness of destructive therapy for anogenital warts in combination with the use of Ingaron in comparison with destructive therapy.

NCT ID: NCT05115669 Completed - Plantar Wart Clinical Trials

Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts

Start date: October 12, 2021
Phase: N/A
Study type: Interventional

This is a Post-Market clinical Follow-up investigation to evaluate the safety and performed of the medical device Wortie Freeze Plus in the treatment of common and plantar warts.

NCT ID: NCT05100043 Completed - Warts Hand Clinical Trials

Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts

Start date: January 3, 2020
Phase:
Study type: Observational

In the present study the investigators assessed the invitro role of IL-4 and IFN-γ in predicting the response to bivalent HPV vaccine after whole blood stimulation

NCT ID: NCT05087849 Recruiting - Clinical trials for Human Papilloma Virus

Intralesional HPV Vaccine for Condylomata

Start date: April 15, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This study will investigate whether injecting genital warts with small quantities of the Gardasil 9 vaccine has an effect on the warts.

NCT ID: NCT05070754 Completed - Verruca Vulgaris Clinical Trials

Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

Start date: December 2, 2021
Phase: Phase 4
Study type: Interventional

This study is going to test a cold atmospheric plasma device (CAP), in particular a floating electrode-dielectric barrier device (FE-DBD), to treat warts and molluscum. The treatment device in this study generates cold atmospheric plasma (gaseous ionized molecules) to rid the virus from the body. Based on the successes of previous dermatologic studies, FE-DBD is being tested for this study to treat warts and molluscum. Patients will be enrolled to test the efficacy and safety of this device. The duration of the study is 4-12 weeks depending on treatment clearance. The number of lesions will be chosen by the dermatologist. Patients will receive standard of care therapy and/or NTAP depending on the number of lesions.

NCT ID: NCT05057663 Not yet recruiting - Plantar Wart Clinical Trials

Intralesional Treatment of Plantar Wart

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Group 1; intralesional injection of bleomycin in plantar wart. Group 2; intralesional injection of 5-fluorouracil in plantar wart

NCT ID: NCT05023408 Completed - Cutaneous Warts Clinical Trials

Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts

Start date: January 1, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study was to determine the efficacy of intralesional bleomycin in comparison to cryotherapy on participants having cutaneous warts.

NCT ID: NCT04947332 Recruiting - Viral Wart Clinical Trials

Auto-inoculation of a Wart in Multiple Viral Warts

Start date: February 8, 2021
Phase: N/A
Study type: Interventional

This study is being conducted to see effectiveness of auto-inoculation of a wart in multiple viral warts. Patients with recurrent, multiple warts of all types, are being recruited for the study. A wart is excised, minced and then inoculated in a subcutaneous pocket made on the volar aspect of forearm. Patients are to be reviewed after every 4 weeks to note any reduction in number warts.